Log in to save to my catalogue

Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Pharmacologic Effect of CP-6...

Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Pharmacologic Effect of CP-6...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_210375008

Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Pharmacologic Effect of CP-690,550 in Patients With Psoriasis

About this item

Full title

Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Pharmacologic Effect of CP-690,550 in Patients With Psoriasis

Publisher

United States: Elsevier Inc

Journal title

Journal of investigative dermatology, 2009-09, Vol.129 (9), p.2299-2302

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Alternative Titles

Full title

Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Pharmacologic Effect of CP-690,550 in Patients With Psoriasis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_210375008

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_210375008

Other Identifiers

ISSN

0022-202X

E-ISSN

1523-1747

DOI

10.1038/jid.2009.25

How to access this item